Innovation in MedTech and Diagnostics Conference London 2025

Innovation in MedTech and Diagnostics Conference London 2025

Tue, 21 Oct 2025

Event Details

Start Date
Tue, 21 Oct 2025 09:00
End Date
Wed, 22 Oct 2025 17:30
Location
Prince Philip House, 3 Carlton House Terrace, London SW1Y 5DG
Cost
£350 + VAT for 2 day event
Share This Page
Events

Innovation in MedTech and Diagnostics Conference London 2025: Connecting the Ecosystem is set to explore the future of diagnostics and healthcare delivery in the UK, spotlighting the nation’s strengths in NHS clinical excellence, innovative R&D, and advanced wound care. 

The agenda features keynote presentations on the next decade of MedTech, with deep dives into decentralisation, AI in pathology, multi‑omics for chronic diseases and sustainable drug delivery.

This dynamic two‑day event will unite 150 experts from academia, healthcare, biotech, pharma and government, offering a mix of invited talks, interactive panels and networking opportunities. Join us to learn from industry pioneers, share ideas and forge new connections within this rapidly advancing field.

Agenda for Day 1: Tuesday 21 October - Innovating the Future of HealthTech

9:00 Registration and breakfast.

9:30 Keynote address: The next ten years for healthtech — visionary insights into the future trajectory of health technologies. Michael Lewis, Scientific Director for Innovation NIHR Programme Director SBRI Healthcare & i4i University of Birmingham Medical School

09:50 Second keynote: Where the UK can play in the future of healthtech? Opportunities and strategies for the UK to lead in global HealthTech innovation - Alex McLaughlin, Deputy Director at Office for Life Sciences 

10:10 Refreshment and networking break

Theme 1: Sensor-enabled management of cardiovascular disease

10:40 Clinical or market need. Exploring the demands and opportunities in cardiovascular health management — Fergus O’Dea, VP at FIRE1

11:00 Technologies or solutions: Highlighting innovative sensor-enabled solutions making waves in the market —  Stephanie Barden, Regional Manager at Biotronik

11:40 Panel discussion
Chaired by: Piotr Sokolowski, Chief MedTech Strategist, S3 Connected Health
Panellists: Dr Ali Vazir, Consultant Cardiologist and Heart Failure Lead at the Royal Brompton Hospital, Stephanie Barden, Regional Manager at Biotronik and Fergus O’Dea, VP at FIRE1

12:10Lunch and networking

Theme 2: Continuous monitoring and treatment for managing wound care

13:10 Theme introduction — Steve Bishop, Medical Technology Consultant

13:20 Clinical or market need — Chris Lawer, CEO at Umio

13:40 Technologies or solutions: a success story — Dmitry Isaev Head of R&D at Natrox Woundcare

14:00 Panel discussion: Industry leaders discuss advancements in wound care monitoring and treatment.
Chaired by: Steve Bishop, Medical Technology Consultant
Panel members: Magdalene Ho, Post-doctural research at Imperial College London, Dmitry Isaev Head of R&D at Natrox Woundcare and Chris Lawer, CEO at Umio.

14:40 Refreshment and networking break

Theme 3: Reducing, replacing, and recycling in drug delivery 

15:10 Introduction to the theme — Bal Johal, Director of R&D at Owen Mumford.

15:20 Clinical or market need -Richard Shaw, Commercial and Sustainability Lead at pd‑m

15:40 Technologies or solutions: a success story — Greg Anderson, Managing Director at Pharmacentric Solutions

16:00 Panel discussion
Chaired by: Bal Johal, Director of R&D at Owen Mumford.
Panellists: Michael Hopkinson, Head of Supply Resilience and Sustainability at the Department of Health and Social Care, Gregor Anderson, Managing Director at Pharmacentric Solutions and David Rakowski, Partner at Deloitte. 

16:40 Closing remarks — Rahul Kapoor, Director of HealthTech at CPI

16:45 Day 1 close.


Agenda for day 2 Wednesday 22 October - Exploring the Future of Diagnostics

9:00 Registration and breakfast

9:30 Keynote address: The next ten years for diagnostics — Insights into emerging trends and innovations set to shape the diagnostics landscape over the next decade — Amit Agrawal, Chief Scientific Officer, Diagnostics Platform at Danaher

09:50 Second keynote: Unlocking opportunities, the UK’s role in shaping the future of diagnostics -Alex McLaughlin, Deputy Director at Office for Life Sciences

10:10 Refreshment and networking break

Theme 1: Decentralisation of diagnostics for infectious disease and anti-microbial resistance (AMR)

10:40 Theme 1 introduction — Giles Sanders, Head of In Vitro Diagnostics at The Technology Partnership

10:50 Emerging clinical demands and the barriers to overcome to realise the market opportunities they present — Jonathan O’Halloran, CEO at Quantum Dx

11:10 Technologies and solutions — Emily Adams, Chief Global Health Officer at Global Access Diagnostics

11:30 Panel discussion: Four industry experts discuss decentralisation strategies.
Chaired by: Giles Sanders from The Technology Partnership
Panellists: Jonathan O’Halloran from Quantum Dx, Emily Adams from Global Access Diagnostics
and Sumeet Mahajan from Brainalyze

12:10 Lunch

Theme 2: The potential for AI in pathology — Resolving complexity and addressing the resource gap

13:10 Theme 2 introduction — Rob Monroe, Chief Scientific Officer at Danaher

13:20 Market need — Greg Verghese, Founder at CTO at PharosAI

13:40 Technologies and solutions: A success story — Donal O’Shea, Chief Executive at Deciphex.

14:00 Panel discussion: Four industry leaders share insights on how AI is transforming pathology:
Chaired by: Rob Monroe from Danaher
Panellists: Donal O’Shea from Deciphex, Greg Verghese from PharosAI, Sanj Lallie from Sourced Path and Dr Alex Haragan from Royal Liverpool University Hospital.

14:40 Refreshment and networking break

Theme 3: The role of multi-omics in managing chronic diseases — From cancer to neurodegenerative diseases

15:10 Theme 3 introduction — Sarah Taylor, Head of Business Development at 10x Genomics

15:20 Clinical need — Nigel Jamieson, Clinical Senior Lecturer, Institute of Cancer Sciences and Honorary HPB surgeon at Glasgow Royal Infirmary

15:40 Quickfire Session 2: Technologies or solutions: a success story - Joseph Beechem, Chief Scientific Officer at Bruker Spatial

16:00 Panel Discussion: Experts discuss how multi-omics is reshaping chronic disease management.
Chaired by: Sarah Taylor from 10x Genomics
Panellists: Nigel Jamieson from Glasgow Royal Infirmary, Joe Beechem from Bruker Spatial and Sumeet Mahajan from Brainalyze.

16:40: Recap key takeaways and discuss actionable insights from the day — Rahul Kapoor, Director of HealthTech at CPI

16:45: End of Conference

Sponsorship Opportunities

There are a number of sponsorship opportunities on offer at the conference and you can find out more in the button below

CPI is your innovation partner to make your ideas a reality.